Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains.

Zhang L, Chang L, Laperche S, Ji H, Zhao J, Jiang X, Wang L, Candotti D.

Emerg Microbes Infect. 2019;8(1):1337-1346. doi: 10.1080/22221751.2019.1663130.

PMID:
31516090
2.

Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose.

Candotti D, Assennato SM, Laperche S, Allain JP, Levicnik-Stezinar S.

Gut. 2019 Feb;68(2):313-321. doi: 10.1136/gutjnl-2018-316490. Epub 2018 Jun 29.

PMID:
29959168
3.

Early MinION™ nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples.

Sauvage V, Boizeau L, Candotti D, Vandenbogaert M, Servant-Delmas A, Caro V, Laperche S.

PLoS One. 2018 Mar 22;13(3):e0194366. doi: 10.1371/journal.pone.0194366. eCollection 2018.

4.

Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?

Candotti D, Laperche S.

Front Med (Lausanne). 2018 Feb 21;5:29. doi: 10.3389/fmed.2018.00029. eCollection 2018. Review.

5.

Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs.

Candotti D, Deng X, Li T, Laperche S, Sauvage V.

Ann Intern Med. 2018 Jan 16;168(2):158. doi: 10.7326/L17-0525. No abstract available. Erratum in: Ann Intern Med. 2018 Mar 6;168(5):384.

PMID:
29335727
6.

Occult hepatitis B infection and transfusion-transmission risk.

Candotti D, Boizeau L, Laperche S.

Transfus Clin Biol. 2017 Sep;24(3):189-195. doi: 10.1016/j.tracli.2017.06.014. Epub 2017 Jun 30. Review.

PMID:
28673499
7.

Molecular characterization of hepatitis B virus in blood donors from Burkina Faso: Prevalence of quasi-subgenotype A3, genotype E, and mixed infections.

Candotti D, Diarra B, Bisseye C, Tao I, Pham Quang K, Sanou M, Laperche S, Sanogo R, Allain JP, Simpore J.

J Med Virol. 2016 Dec;88(12):2145-2156. doi: 10.1002/jmv.24589. Epub 2016 Jun 14.

PMID:
27253483
8.

Poor efficacy of nucleic acid testing in identifying occult HBV infection and consequences for safety of blood supply in Italy.

Spreafico M, Berzuini A, Foglieni B, Candotti D, Raffaele L, Guarnori I, Colli A, Maldini FF, Allain JP, Prati D.

J Hepatol. 2015 Nov;63(5):1068-76. doi: 10.1016/j.jhep.2015.06.016. Epub 2015 Jun 24.

PMID:
26116791
9.

Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors.

Enjalbert F, Krysztof DE, Candotti D, Allain JP, Stramer SL.

Transfusion. 2014 Oct;54(10):2485-95. doi: 10.1111/trf.12653. Epub 2014 Apr 17.

PMID:
24738835
10.

Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection.

Biswas S, Candotti D, Allain JP.

J Virol. 2013 Jul;87(14):7882-92. doi: 10.1128/JVI.00710-13. Epub 2013 May 8.

11.

Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors.

Grabarczyk P, van Drimmelen H, Kopacz A, Gdowska J, Liszewski G, Piotrowski D, Górska J, Kuśmierczyk J, Candotti D, Lętowska M, Lelie N, Brojer E.

Transfusion. 2013 Oct;53(10 Pt 2):2512-24. doi: 10.1111/trf.12190. Epub 2013 Apr 17.

PMID:
23590145
12.

Infectivity of blood products from donors with occult hepatitis B virus infection.

Allain JP, Mihaljevic I, Gonzalez-Fraile MI, Gubbe K, Holm-Harritshøj L, Garcia JM, Brojer E, Erikstrup C, Saniewski M, Wernish L, Bianco L, Ullum H, Candotti D, Lelie N, Gerlich WH, Chudy M.

Transfusion. 2013 Jul;53(7):1405-15. doi: 10.1111/trf.12096. Epub 2013 Jan 30.

PMID:
23362802
13.

Molecular virology in transfusion medicine laboratory.

Candotti D, Allain JP.

Blood Transfus. 2013 Apr;11(2):203-16. doi: 10.2450/2012.0219-12. Epub 2012 Dec 21. Review. No abstract available.

14.

Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa.

Gobbini F, Owusu-Ofori S, Marcelin AG, Candotti D, Allain JP.

Transfusion. 2012 Nov;52(11):2294-9. doi: 10.1111/j.1537-2995.2012.03607.x. Epub 2012 Mar 15.

PMID:
22420900
15.

Hepatitis B virus in transfusion medicine: still a problem?

Allain JP, Candotti D; ISBT HBV Safety Collaborative Group.

Biologicals. 2012 May;40(3):180-6. doi: 10.1016/j.biologicals.2011.09.014. Epub 2012 Feb 2. Review.

PMID:
22305086
16.

Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.

Candotti D, Lin CK, Belkhiri D, Sakuldamrongpanich T, Biswas S, Lin S, Teo D, Ayob Y, Allain JP.

Gut. 2012 Dec;61(12):1744-53. doi: 10.1136/gutjnl-2011-301281. Epub 2012 Jan 20.

PMID:
22267593
17.

Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother.

Niederhauser C, Candotti D, Weingand T, Maier A, Tinguely C, Stolz M, Allain JP.

J Hepatol. 2012 Mar;56(3):734-7. doi: 10.1016/j.jhep.2011.07.034. Epub 2011 Oct 23.

18.

Characterization of occult hepatitis B virus infection from blood donors in China.

Zheng X, Ye X, Zhang L, Wang W, Shuai L, Wang A, Zeng J, Candotti D, Allain JP, Li C.

J Clin Microbiol. 2011 May;49(5):1730-7. doi: 10.1128/JCM.00145-11. Epub 2011 Mar 16.

19.

Nucleic acid testing to detect HBV infection in blood donors.

Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W.

N Engl J Med. 2011 Jan 20;364(3):236-47. doi: 10.1056/NEJMoa1007644.

20.

A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays.

Foglieni B, Candotti D, Guarnori I, Raffaele L, Berzuini A, Spreafico M, Orani A, Rossotti R, Rossi D, Allain JP, Prati D.

Transfusion. 2011 Apr;51(4):719-30. doi: 10.1111/j.1537-2995.2010.02942.x. Epub 2010 Nov 18.

PMID:
21087286
21.

Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan.

Mahgoub S, Candotti D, El Ekiaby M, Allain JP.

J Clin Microbiol. 2011 Jan;49(1):298-306. doi: 10.1128/JCM.00867-10. Epub 2010 Nov 3.

22.

Prevalence and genetic heterogeneity of SEN virus genotypes D and H in blood donors from Central and Western Europe and West Africa.

Thom K, Cleland A, Salakova M, Candotti D, Petrik J.

Transfus Med. 2011 Feb;21(1):42-50. doi: 10.1111/j.1365-3148.2010.01039.x. Epub 2010 Sep 30.

PMID:
20880324
23.

Impact of hepatitis B virus surface protein mutations on the diagnosis of occult hepatitis B virus infection.

El Chaar M, Candotti D, Crowther RA, Allain JP.

Hepatology. 2010 Nov;52(5):1600-10. doi: 10.1002/hep.23886.

PMID:
20815025
24.

HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus.

Power JP, El Chaar M, Temple J, Thomas M, Spillane D, Candotti D, Allain JP.

J Hepatol. 2010 Oct;53(4):780-7. doi: 10.1016/j.jhep.2010.04.034. Epub 2010 Jun 27.

25.

Fatal outcome of a hepatitis B virus transfusion-transmitted infection.

Niederhauser C, Weingand T, Candotti D, Maier A, Tinguely C, Wuillemin WA, Gowland P, Allain JP, Stolz M.

Vox Sang. 2010 May;98(4):504-7. doi: 10.1111/j.1423-0410.2009.01304.x. Epub 2010 Jan 11.

PMID:
20070649
26.

Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays.

Baylis SA, Chudy M, Blümel J, Pisani G, Candotti D, José M, Heath AB.

Vox Sang. 2010 Apr;98(3 Pt 2):441-6. doi: 10.1111/j.1423-0410.2009.01288.x. Epub 2009 Dec 8.

PMID:
20003130
27.

Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.

González R, Torres P, Castro E, Barbolla L, Candotti D, Koppelman M, Zaaijer HL, Lelie N, Allain JP, Echevarría JM.

Transfusion. 2010 Jan;50(1):221-30. doi: 10.1111/j.1537-2995.2009.02343.x. Epub 2009 Aug 4.

PMID:
19682332
28.

Diagnostic algorithm for HBV safe transfusion.

Allain JP, Candotti D.

Blood Transfus. 2009 Jul;7(3):174-82. doi: 10.2450/2008.0062-08. Review. No abstract available.

29.

Transfusion-transmitted hepatitis B virus infection.

Candotti D, Allain JP.

J Hepatol. 2009 Oct;51(4):798-809. doi: 10.1016/j.jhep.2009.05.020. Epub 2009 Jun 10. Review.

30.

Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa.

Garmiri P, Loua A, Haba N, Candotti D, Allain JP.

J Gen Virol. 2009 Oct;90(Pt 10):2442-51. doi: 10.1099/vir.0.012013-0. Epub 2009 Jun 17.

PMID:
19535503
31.

Characterization of occult hepatitis B virus strains in South African blood donors.

Allain JP, Belkhiri D, Vermeulen M, Crookes R, Cable R, Amiri A, Reddy R, Bird A, Candotti D.

Hepatology. 2009 Jun;49(6):1868-76. doi: 10.1002/hep.22879.

PMID:
19434719
32.

HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.

Fausther-Bovendo H, Sol-Foulon N, Candotti D, Agut H, Schwartz O, Debré P, Vieillard V.

AIDS. 2009 Jun 1;23(9):1077-87. doi: 10.1097/QAD.0b013e32832cb26b.

PMID:
19424050
33.

Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains.

Candotti D, Grabarczyk P, Ghiazza P, Roig R, Casamitjana N, Iudicone P, Schmidt M, Bird A, Crookes R, Brojer E, Miceli M, Amiri A, Li C, Allain JP.

J Hepatol. 2008 Oct;49(4):537-47. doi: 10.1016/j.jhep.2008.04.017. Epub 2008 Jun 2.

PMID:
18602718
34.

Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions.

Compston LI, Sarkobie F, Li C, Candotti D, Opare-Sem O, Allain JP.

J Virol Methods. 2008 Jul;151(1):47-54. doi: 10.1016/j.jviromet.2008.03.023. Epub 2008 May 13.

PMID:
18479760
35.

A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period.

Wendel S, Levi JE, Biagini S, Candotti D, Allain JP.

Transfusion. 2008 Aug;48(8):1602-8. doi: 10.1111/j.1537-2995.2008.01723.x. Epub 2008 May 2.

PMID:
18466175
36.

Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients.

Levicnik-Stezinar S, Rahne-Potokar U, Candotti D, Lelie N, Allain JP.

J Hepatol. 2008 Jun;48(6):1022-5. doi: 10.1016/j.jhep.2008.02.016. Epub 2008 Mar 28.

37.

Molecular characterization of occult hepatitis B virus in genotype E-infected subjects.

Zahn A, Li C, Danso K, Candotti D, Owusu-Ofori S, Temple J, Allain JP.

J Gen Virol. 2008 Feb;89(Pt 2):409-18. doi: 10.1099/vir.0.83347-0.

PMID:
18198371
38.

Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa.

Candotti D, Danso K, Allain JP.

J Gen Virol. 2007 Oct;88(Pt 10):2686-95.

PMID:
17872520
39.

Human erythrovirus B19 and blood transfusion - an update.

Parsyan A, Candotti D.

Transfus Med. 2007 Aug;17(4):263-78. Review.

PMID:
17680952
40.

The utility of multiplex NAT in blood screening.

Candotti D, Allain JP.

Dev Biol (Basel). 2007;127:71-86. Review. No abstract available.

PMID:
17486882
41.

Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes.

Parsyan A, Szmaragd C, Allain JP, Candotti D.

J Gen Virol. 2007 Feb;88(Pt 2):428-31.

PMID:
17251559
42.

Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase.

Candotti D, Opare-Sem O, Rezvan H, Sarkodie F, Allain JP.

J Viral Hepat. 2006 Nov;13(11):715-24.

PMID:
17052270
43.

Maternal-fetal transmission of human parvovirus B19 genotype 3.

Candotti D, Danso K, Parsyan A, Dompreh A, Allain JP.

J Infect Dis. 2006 Sep 1;194(5):608-11. Epub 2006 Jul 24.

PMID:
16897659
44.

GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.

Li C, Collini P, Danso K, Owusu-Ofori S, Dompreh A, Candotti D, Opare-Sem O, Allain JP.

AIDS. 2006 Feb 14;20(3):379-86.

PMID:
16439871
45.

Predonation testing of potential blood donors in resource-restricted settings.

Owusu-Ofori S, Temple J, Sarkodie F, Candotti D, Allain JP.

Transfusion. 2005 Sep;45(9):1542-3. No abstract available.

PMID:
16131391
46.

Simultaneous visual detection of multiple viral amplicons by dipstick assay.

Dineva MA, Candotti D, Fletcher-Brown F, Allain JP, Lee H.

J Clin Microbiol. 2005 Aug;43(8):4015-21.

47.

Persistent B19 infection in immunocompetent individuals: implications for transfusion safety.

Lefrère JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, Lefrère F, Girot R, Allain JP, Laperche S.

Blood. 2005 Oct 15;106(8):2890-5. Epub 2005 Jun 23.

48.

Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.

Allain JP, Sarkodie F, Candotti D, Opare-Sem O.

Transfusion. 2005 Jun;45(6):1039-40. No abstract available.

PMID:
15935007
49.

Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections.

Corcoran A, Doyle S, Allain JP, Candotti D, Parsyan A.

J Virol. 2005 Apr;79(8):5238-9; author reply 5239. No abstract available.

50.

Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings.

Owusu-Ofori S, Temple J, Sarkodie F, Anokwa M, Candotti D, Allain JP.

Transfusion. 2005 Feb;45(2):133-40.

PMID:
15660820

Supplemental Content

Loading ...
Support Center